BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 8697635)

  • 1. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
    Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
    Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
    Tuaillon E; Tabaa YA; Petitjean G; Huguet MF; Pajeaux G; Fondere JM; Ponseille B; Ducos J; Blanc P; Vendrell JP
    J Immunol Methods; 2006 Aug; 315(1-2):144-52. PubMed ID: 16959261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
    Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
    Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
    Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
    Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional implications of hepatitis B surface antigen (HBsAg) in the T cells of chronic HBV carriers.
    Nagaraju K; Naik SR; Naik S
    J Viral Hepat; 1997 Jul; 4(4):221-30. PubMed ID: 9278219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity.
    Makhlouf NA; Farghaly AM; Zaky S; Rashed HA; Abu Faddan NH; Sayed D; El-Badawy O; Afifi N; Hamza WS; El-Sayed Y
    J Med Virol; 2016 Sep; 88(9):1567-75. PubMed ID: 26910304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
    Akbar SM; Abe M; Masumoto T; Horiike N; Onji M
    J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B.
    Murase K; Kakumu S; Tsubouchi A; Yoshioka K; Sakamoto N
    Gastroenterol Jpn; 1986 Apr; 21(2):145-51. PubMed ID: 2940143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and Cellular Responses to a Single Dose of Fendrix in Renal Transplant Recipients with Non-response to Previous Hepatitis B Vaccination.
    Lindemann M; Zaslavskaya M; Fiedler M; Wilde B; Heinemann FM; Heinold A; Horn PA; Witzke O
    Scand J Immunol; 2017 Jan; 85(1):51-57. PubMed ID: 27763680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.